ArticleJournal of diabetes science and technology2022
Level of Digitalization in Germany: Results of the Diabetes Digitalization and Technology (D.U.T) Report 2020.
Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 11 citations in OpenAlex.
- Perceptions of Suboptimal Insulin Dosing from People with Diabetes and Healthcare Professionals in Germany.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- European Survey on Adult People With Type 1 Diabetes and Their Caregivers: Insights into Perceptions of Technology.Journal of diabetes science and technology · 2025Article
- Impact of a digital application on HbA1c levels in people with diabetes: a randomized controlled trial.Frontiers in digital health · 2025Article
- Therapies go digital. What drives physicians' acceptance?PloS one · 2024Article
- Patients' Experience of New Technologies and Digitalization in Diabetes Care in Germany.Journal of diabetes science and technology · 2022Article
- Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes.Diabetologia · 2022Review
- Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends.Diabetes spectrum : a publication of the American Diabetes Association · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNew diagnostic and therapeutic technologies are increasingly changing the treatment of people with diabetes (PWD), along with increased usage of digital tools. To date, however, there is little data to which level and how diabetologists and PWD implement digitalization. Also, not much is known about the view of diabetologists on the current status and future developments in this respect.
methodIn an online survey, diabetologists working in clinics and practices across Germany provided responses regarding their view on digitalization and the adoption of new technologies in diabetology to 56 questions. These comments reflect the opinion of several experts about the current importance and use of specific digital/technological topics.
resultsOverall, 326 diabetologists took part in the survey. They reported a positive attitude (75.8%) toward new technologies and digitalization, and they see more advantages rather than disadvantages. Younger age of the diabetologists was significantly associated with a more positive attitude (
conclusionsThis survey, which is going to be repeated annually, showed that the diabetologists who participated predominantly have a positive attitude toward new technologies and digital applications and were aware of the associated advantages. However, perceived disadvantages need to be addressed to enable wider adoption of new technologies and digital solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.